JPMorgan upgrades CME Group stock to Overweight at USD 367

Published on 10/27/2026 at 10:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JPMorgan upgraded CME Group to Overweight at USD 367 on October 22, 2026. CME Group stock costs EUR 276.25 on October 27, 2026.

Analyst upgrade and earnings strength

JPMorgan upgraded CME Group from Underweight to Overweight at USD 367 on October 22, 2026.
Third-quarter 2026 revenue reached USD 1.74 billion, while average daily volume hit 29.4 million contracts.
CME Group stock trades at EUR 276.25 at 10:31 a.m. CET at Lang & Schwarz on October 27, 2026.
Market data revenue rose 20.00 percent to USD 243 million in the third quarter of 2026.

CME Group Inc., US12572Q1058, Illustration mit AI erstellt.

CME Group Inc. (ISIN US12572Q1058) was upgraded by JPMorgan from Underweight to Overweight, with a USD 367.00 price target, according to MarketBeat on October 22, 2026. The analyst action followed a record third-quarter revenue report.

Record revenue meets analyst support

CME Group reported USD 1.74 billion in revenue for the third quarter of 2026, up from USD 1.54 billion in the third quarter of 2025. Operating income increased to USD 1.14 billion from USD 972.6 million, while diluted GAAP earnings per share rose to USD 2.89 from USD 2.49.

The adjusted figures were also higher. Adjusted diluted earnings per share reached USD 3.02 in the third quarter of 2026, compared with USD 2.68 a year earlier, and adjusted operating income was USD 1.21 billion versus USD 1.05 billion.

What drives the latest revenue record?

The key driver was activity across the exchange operator's products. Average daily volume reached 29.4 million contracts in the third quarter of 2026, compared with 25.3 million in the third quarter of 2025. Non-US average daily volume reached 9.0 million contracts.

Market data revenue supplied another growth channel, rising 20.00 percent year over year to USD 243 million in the third quarter of 2026. CME Group also returned USD 989 million to shareholders during the quarter through USD 465 million in regular dividends and USD 524 million in share repurchases, according to the company release dated October 21, 2026.

Three recent signals for CME

On October 14, 2026, Wells Fargo raised its target to USD 315.00 from USD 301.00, according to MarketBeat. CME Group then reported third-quarter revenue of USD 1.74 billion on October 21, 2026, before JPMorgan announced its rating change and USD 367.00 target on October 22, 2026.

Stock valuation and trading context

CME Group's primary listing is on Nasdaq under ticker CME. The stock's market capitalization was USD 110.8 billion as of October 26, 2026, while the twelve-month range was USD 218.31 to USD 329.16. These figures place the latest US-market quotation inside its established annual band.

CME Group operates futures, options, cash and over-the-counter markets across interest rates, equity indexes, foreign exchange, energy, agriculture and metals. The company also operates CME Clearing, BrokerTec and EBS, giving the volume figure a direct link to both transaction fees and market-data demand.

Trading price on October 27

For investors, the earnings picture combines higher activity with a valuation that still depends on sustained volume and market-data growth. CME Group was trading at EUR 276.25 at Lang & Schwarz on October 27, 2026 at 10:31 a.m. CET.

The further course of trading is shown by the continuously updated real-time quote of CME Group stock.